Phytomedicine (2019) 57:15865
Biologics [e.g., TNF- inhibitors (etanercept), IL-6R blockers (tocilizumab)]: Effective in 60 - 70% of patients but incur prohibitive costs ($20,000 - 50,000 annually), limiting accessibility (only 10 - 20% treated in low-resource settings) (5, 6)
Of the participants, 12.2% receiving 9 mg retatrutide, 18.2% receiving 12 mg retatrutide and 4% receiving placebo discontinued treatment due to adverse events
The annual flu vaccine is designed to protect against the most common strains expected to circulate in the upcoming flu season
licensed healthcare providers evaluate and prescribe when appropriate, and partner pharmacies dispense and label medications
3 The pharmaceutical industry lobbied for Patent Term Extensions under the Hatch-Waxman Act 1984 to ensure they would be guaranteed up to 14 years of market protection from the date of a products approval